Lv11
40 积分 2024-05-03 加入
A phase II study of paclitaxel and carboplatin plus PD-1 inhibitors combined with anlotinib as first-line treatment for advanced esophageal cancer
3小时前
求助中
Immune checkpoint inhibitor associated epidermal necrosis, beyond SJS and TEN: a review of 98 cases
8个月前
已完结
Tocilizumab for Corticosteroid-Refractory Immune Checkpoint Inhibitor–Induced Generalized Morphea
8个月前
已完结
Skin Reactions to Immune Checkpoint Inhibitors
8个月前
已完结
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases
8个月前
已完结
Fisetin, a dietary flavonoid, increases the sensitivity of chemoresistant head and neck carcinoma cells to cisplatin possibly through HSP90AA1/IL‐17 pathway
10个月前
已完结
皖公网安备34019202002308
